Literature DB >> 33502848

Beneficent and Maleficent Effects of Cations on Bufadienolide Binding to Na+,K+-ATPase.

Lucy Kate Ladefoged1,2, Birgit Schiøtt2, Natalya U Fedosova1.   

Abstract

Kinetic properties and crystal structures of the Na+,K+-ATPase in complex with cardiotonic steroids (CTS) revealed significant differences between CTS subfamilies (Laursen et al.). Thus, we found beneficial effects of K+ on bufadienolide binding, which strongly contrasted with the well-known antagonism between K+ and cardenolides. In order to understand this peculiarity of bufalin interactions, we used docking and molecular dynamics simulations of the complexes involving Na+,K+-ATPase, bufadienolides (bufalin, cinobufagin), and ions (K+, Na+, Mg2+). The results revealed that bufadienolide binding is affected by (i) electrostatic attraction of the lactone ring by a cation and (ii) the ability of a cation to stabilize and "shape" the site constituted by transmembrane helices of the α-subunit (αM1-6). The latter effect was due to varying coordination patterns involving amino acid residues from helix bundles αM1-4 and αM5-10. Substituents on the steroid core of a bufadienolide add to and modify the cation effects. The above rationale is fully consistent with the ion effects on the kinetics of Na+,K+-ATPase/bufadienolide interactions.

Entities:  

Year:  2021        PMID: 33502848     DOI: 10.1021/acs.jcim.0c01396

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  2 in total

1.  Geometry and water accessibility of the inhibitor binding site of Na+-pump: Pulse- and CW-EPR study.

Authors:  Erika Aloi; Jin-Hua Guo; Rita Guzzi; Ren-Wang Jiang; Lucy Kate Ladefoged; Derek Marsh; Mikael Esmann; Rosa Bartucci; Natalya U Fedosova
Journal:  Biophys J       Date:  2021-06-02       Impact factor: 3.699

2.  Advanced Electrostatic Model for Monovalent Ions Based on Ab Initio Energy Decomposition.

Authors:  Zhifeng Jing; Chengwen Liu; Pengyu Ren
Journal:  J Chem Inf Model       Date:  2021-06-07       Impact factor: 6.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.